To bring innovation and hope to the treatment of infectious diseases requires focus and commitment.
Already established as a leader in the fields of Transplantation and Urology, Astellas has also been applying its technical expertise and experience to Anti-infective agents. With active R&D programmes advancing therapies for serious fungal and bacterial infections, we will continue our commitment to this field as we strive to deliver pioneering treatments to address the evolving needs in this complex area. We trust that you will get to know us better as we work together to provide patients with the promise of a brighter tomorrow.
Learn more about our therapy areas:
Innovative therapies in preventing organ rejection after transplantation
World-leading approach in R&D to satisfy unmet patient needs in urological conditions
Our commitment is to developing first-in-class and best-in-class therapies
Addressing the complex challenges of serious fungal and bacterial infections
Pioneering treatments that effectively manage chronic pain